Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will expand product portfolio; names Debby Saunders executive director
January 30, 2017
By: Tim Wright
Editor-in-Chief, Contract Pharma
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has unveiled plans to increase focus on the life science division of the organization. CrownBio’s life science division currently provides more than one hundred products across a portfolio of antibodies for in vivo and in vitro studies, recombinant proteins, recombinant cell lines, tumor samples for oncology research and drug development, immune checkpoint antibodies, and tumor tissue microarrays. Driven by market demand, CrownBio is investing in expanding the division and forecasts triple digit growth in 2017. The investment includes an addition to the leadership team with the appointment of Debby Saunders, as executive director of life science development. In support of the expansion in 2017, CrownBio says it will more than double their offering of recombinant cell lines covering important targets and pathways in oncology. Further expansion of CrownBio’s product catalog includes tumor tissue microarrays, allowing for rapid assay screening of molecular targets and diagnostic and prognostic markers, as well as high quality immune checkpoint antibodies to detect immune regulators, some of which will be suitable for in vivo use. “This investment in new products and leadership demonstrates our ongoing commitment to bring to market an expanding toolset to help advance the rate of scientific breakthrough for oncology drug discovery and development,” said Laurie Heilmann, senior vice president, global strategy, marketing and business development, CrownBio.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !